AAOS Now, October 2008
AAOS adopts CTS clinical treatment guidelines
During its September meeting, the AAOS Board of Directors adopted a new clinical practice guideline on the treatment of carpal tunnel syndrome (CTS). Kristy L. Weber, MD, chair of the Council on Research, Quality Assessment and Technology, presented the guidelines, which were developed by a workgroup appointed by the Guidelines and Technology Oversight Committee. The Guideline Workgroup on the treatment of CTS was chaired by Michael W. Keith, MD, and cochair Victoria Masear, MD.
Orthopaedists and industry: Working together—at arm’s length
One year later, uncertainty continues This time last year, the orthopaedic industry was struggling to respond to the terms of a settlement reached by the US Attorney’s office for New Jersey (Department of Justice, DOJ) with five major orthopaedic hip and knee manufacturers. The settlements appear to have permanently altered the relationships between orthopaedic surgeons and industry. They continue to have a ripple effect in education funding, research, clinical care, and humanitarian efforts.
MRSA: From the hospital and into the community
A more virulent form of these bacteria challenges the orthopaedic community The death of Ricky Lannetti, a senior at Lycoming College and a wide receiver on the football team, in 2003 due to community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) marked a turning point in awareness about the disease. “In the 1980s, we started hearing about ‘community-acquired MRSA,’” said Kathleen Weber, MD, MS, at the annual meeting of the American Orthopaedic Society of Sports Medicine.